Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same

• US 6,689,610 B1
• Filed: 11/28/2000
• Issued: 02/10/2004
• Est. Priority Date: 08/22/1989
• Status: Expired due to Fees

• Current Assignee: University of Utah Research Foundation (State of Utah)
• Original Assignee: University of Utah Research Foundation (State of Utah)
• Inventors: Capecchi, Mario R., Thomas, Kirk R.
• Primary Examiner(s): FALK, ANNE MARIE
• Application Number:
  US09/724,962
• Time in Patent Office: 1,169 Days
• Field of Search: 435/325, 435/455, 435/463, 435/352, 435/354, 435/363, 435/366, 435/368, 435/371, 435/372, 435/419, 800/278
• US Class Current: 435/463
• CPC Class Codes: A01K 2217/05 Animals comprising random inserted nucleic acids (transgenic)
• CPC Class Codes: A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
• CPC Class Codes: C07K 14/47 from mammals
• CPC Class Codes: C07K 14/50 Fibroblast growth factor [FGF]
• CPC Class Codes: C07K 14/755 Factors VIII , e.g. factor VIII C (AHF), factor VIII Ag (VWF)
• CPC Class Codes: C12N 15/8209 Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers
• CPC Class Codes: C12N 15/8213 Targeted insertion of genes into the plant genome by homologous recombination
• CPC Class Codes: C12N 15/907 in mammalian cells
• CPC Class Codes: C12N 9/1077 Pentosyltransferases (2.4.2)

Abstract

Positive-negative selector (PNS) vectors are provided for modifying a target DNA sequence contained in the genome of a target cell capable of homologous recombination. The vector comprises a first DNA sequence which contains at least one sequence portion which is substantially homologous to a portion of a first region of a target DNA sequence. The vector also includes a second DNA sequence containing at least one sequence portion which is substantially homologous to another portion of a second region of a target DNA sequence. A third DNA sequence is positioned between the first and second DNA sequences and encodes a positive selection marker which when expressed is functional in the target cell in which the vector is used. A fourth DNA sequence encoding a negative selection marker, also functional in the target cell, is positioned 5′ to the first or 3′ to the second DNA sequence and is substantially incapable of homologous recombination with the target DNA sequence. The invention also includes transformed cells containing at least one predetermined modification of a target DNA sequence contained in the genome of the cell. In addition, the invention includes organisms such as non-human transgenic animals and plants which contain cells having predetermined modifications of a target DNA sequence in the genome of the organism.

Claims

1. A method for selecting a transformed cell containing a modification in a target DNA sequence in the genome of said cell comprising:

(a) transfecting cells capable of mediating homologous recombination with a positive-negative selection vector comprising;

a first homologous vector DNA sequence capable of homologous recombination with a first region of said target DNA sequence,

a positive selection marker DNA sequence that confers a phenotype to allow selection of cells expressing the positive selection marker,

a second homologous vector DNA sequence capable of homologous recombination with a second region of said target DNA sequence, and

a negative selection marker DNA sequence that confers a phenotype that allows selection, other than by killing, against cells expressing the negative selection marker, the negative selection marker being substantially incapable of homologous recombination with said target DNA sequence,

wherein the spatial order of said sequences in said PNS vector is;

said first homologous vector DNA sequence, said positive selection marker DNA sequence, said second homologous vector DNA sequence and said negative selection marker DNA sequence as shown in FIG. 1,

wherein the 5′

-3′

orientation of said first homologous vector sequence relative to said second homologous vector sequence is the same as the 5′

-3′

orientation of said first region relative to said second region of said target sequence;

wherein the vector is capable of modifying the target DNA sequence by homologous recombination of said first and second homologous vector sequence with the first and second regions of said target sequence;

(b) selecting for transformed cells in which said positive-negative selection vector has integrated into said target DNA sequence by homologous recombination by sequentially or simultaneously selecting against transformed cells containing said negative selection marker and selecting for cells containing said positive selection marker, and

(c) analyzing the DNA of transformed cells surviving the selection step to identify a cell containing the modification.

2. The method of claim 1, further comprising introducing a second modification into the genome of said cell or a cell propagated therefrom.

3. The method of claim 1, wherein said cells are derived from a multicellular organism and are capable of homologous recombination.

4. The method of claim 1, wherein said cells are plant cells capable of homologous recombination.

5. The method of claim 1, wherein said cells are animal cells capable of homologous recombination.

6. The method of claim 1, wherein said cells are selected from the group consisting of hematopoietic, epithelial, liver, lung, bone marrow, endothelial, mesenchymal, neural and muscle stem cells.

7. The method of claim 1, wherein said cells are human cells.

8. The method of claim 1, wherein said cells are bone marrow stem cells.

9. The method of claim 1, wherein said cells are simian cells.

10. The method of claim 1, wherein said cells are mouse cells.

11. The method of claim 1, wherein said cells are mouse embryonic stem cells.

12. The method of claim 1, wherein the positive selection marker confers a phenotype that allows selection for cells expressing the positive selection marker without killing of other cells.

13. The method of claim 1, wherein the positive selection marker is a membrane bound protein, and the method further comprises contacting cells expressing the positive selection marker with fluorescently labelled antibodies that bind to an extracellular domain of the membrane bound protein, and detecting bound fluorescently labelled antibodies using a fluorescent activated cell sorter.

14. The method of claim 1, wherein the selecting against transformed cells containing the negative selection marker further comprises contacting the cells with an agent that in combination with the negative selection marker confers the phenotype.

15. The method of claim 1, wherein step (b) further comprises contacting the cells with an agent which in combination with the positive selection marker confers the phenotype.

16. The method of claim 1, wherein the positive selection marker is a fluorescently labelled membrane bound protein and the agent is ultraviolet irradiation.